Search - tctmd.com

Displaying 701 - 720 of 1464

Sort: Relevancy | Date

Run to Your Heart’s Content: Marathons Not Linked With Subclinical Atherosclerosis

News Daily News

Run to Your Heart’s Content: Marathons Not Linked With Subclinical Atherosclerosis

Michael O'Riordan

June 09, 2017

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

News Daily News

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

Michael O'Riordan

June 06, 2017

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

News Features EuroPCR 2017

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

Yael L. Maxwell

June 01, 2017

Cardiac Recovery Possible in Patients With Cardiomyopathy Related to Methamphetamine Abuse

News Daily News

Cardiac Recovery Possible in Patients With Cardiomyopathy Related to Methamphetamine Abuse

May 30, 2017

News Industry News

STENTYS: Follow-Up of the APPOSITION IV and OPEN II Clinical Trials at Respectively 3 and 4 Years Confirms the Initial Positive Study Outcomes

May 25, 2017

EWOLUTION Analysis Backs LAA Closure in High-Risk Patients Taking DAPT, Not Warfarin, After Procedure

News Conference News EuroPCR 2017

EWOLUTION Analysis Backs LAA Closure in High-Risk Patients Taking DAPT, Not Warfarin, After Procedure

Michael O'Riordan

May 24, 2017

Two New Trials Buoy Outlook for PFO Closure in Patients With Cryptogenic Stroke

News Daily News

Two New Trials Buoy Outlook for PFO Closure in Patients With Cryptogenic Stroke

May 24, 2017

More Early Stroke With SAVR Than TAVR in SURTAVI

News Conference News EuroPCR 2017

More Early Stroke With SAVR Than TAVR in SURTAVI

May 18, 2017

EUROCTO: Revascularization Bests Medical Therapy for Quality of Life in CTO Lesions

News Conference News EuroPCR 2017

EUROCTO: Revascularization Bests Medical Therapy for Quality of Life in CTO Lesions

Yael L. Maxwell

May 18, 2017

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

News Conference News EuroPCR 2017

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

May 17, 2017

REPRISE III: Lotus Valve Matches CoreValve in First Head-to-Head TAVR Trial

News Conference News EuroPCR 2017

REPRISE III: Lotus Valve Matches CoreValve in First, Large Head-to-Head TAVR Trial

May 16, 2017

DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit

News Conference News EuroPCR 2017

DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit

Michael O'Riordan

May 16, 2017

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

News Features

Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions

Michael O'Riordan

May 08, 2017

News Industry News

Abbott Announces CE Mark and First Use of the World's First Smartphone Compatible Insertable Cardiac Monitor

May 08, 2017

Stents as Essential Medicine: India’s Cap on Stent Prices Could Have Ripples Around the Globe

News Features

Stents as Essential Medicine: India’s Cap on Stent Prices Could Have Ripples Around the Globe

May 05, 2017

Extended DAPT May Benefit Patients With CAD and PAD, but With Caveats

News Daily News

Extended DAPT May Benefit Patients With CAD and PAD, but With Caveats

May 03, 2017

Oktoberfest Revelers Show That Drinking Alcohol Gets the Heart Racing

News Daily News

Oktoberfest Revelers Show That Drinking Alcohol Gets the Heart Racing

April 26, 2017

Genetic Predisposition to CAD Gets a Boost From Socioeconomics

News Daily News

Genetic Predisposition to CAD Gets a Boost From Socioeconomics

April 20, 2017

Score May Ease Risk Stratification in Acute MI-Related Cardiogenic Shock

News Daily News

Score May Ease Risk Stratification in Acute MI-Related Cardiogenic Shock

April 10, 2017

News Industry News

Eurocor announces the completion of the Freeway Stent Study

April 04, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.